Octapharma is the world's largest privately-owned, independent company specializing in the field of blood plasma fractionation. With over 11,000 employees, we lead in the development and production of essential human proteins derived from human plasma and human cell lines.
We support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology, and Critical Care.
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centres across Europe and the US.
📍Octapharma Stockholm, Sweden
• The only private owned manufacturer of blood plasma-based pharmaceuticals in the Nordics.
• Pharmaceutical production, technology, quality assurance, supply chain, marketing, sales, and finance
• Approximately 1000 employees in Stockholm
Community guidelines: https://bit.ly/3M8ioml
Company Details
- Employees
- 517
- Founded
- -
- Address
- Lars Forssells Gata 23, Stockholm,stockholm 11275,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://octapharma.se
- HQ
- Stockholm, Stockholm
Octapharma Sweden Questions
Octapharma Sweden's website is http://octapharma.se
Octapharma Sweden's LinkedIn profile is https://www.linkedin.com/company/octapharma-sweden
Octapharma Sweden has
517 employees.
View email and phone details for 517
employees at Octapharma Sweden.
Octapharma Sweden's industry is
Pharmaceutical Manufacturing
Octapharma Sweden's top competitors are
Astrazeneca,
Octapharma,
Apl (Apotek Produktion & Laboratorier Ab),
Scilifelab,
Olink Proteomics,
Octapharma Plasma, Inc.,
Bioarctic,
Biolamina,
Cytiva,
Northx Biologics.
Octapharma Sweden's categories are Pharmaceutical Manufacturing
Octapharma Sweden's founding year is 1983
